Page 33 - MemoriaDEM-Eng

www.ciberdem.org

As regards study monitoring, the first monitoring visits were performed in the di-
fferent participating hospitals and patient recruitment began.

Finalist in the Ecotendencias Cosmocaixa video competition.

The main results obtained from the study will determine the effect of long-term

sardine intake on glucose levels and glycosylated hemoglobin values. They will also

allow obtaining information on its effects on inflammation markers and cardiovas-
cular risk factors associated with type 2 diabetes (blood pressure and lipid profile).

The study will generate new scientific knowledge in the field of nutrition in diabetes

which will contribute to the consideration of future applications in the treatment
of type 2 diabetes, allowing making sardine-based dietary recommendations for

patients with diabetes and with other metabolic diseases associated with obesity.

The use of sardines in cooking will also be improved, with influences on the eating

habits of patients, their relatives and society as a whole. Taking into consideration
the expected increase in the prevalence of type 2 diabetes over the next few years, ó

the results of this novel study will have an impact on public health because they

will lay the foundations for new studies in the field of nutrition strategies in type 2
diabetes.
ñ

á

MEDIGENE STUDY

èó
European Project

Estado: Development

The MEDIGENE Study is a study on the genetic and environmental factors influen- é
í
cing insulin resistance syndrome in Mediterranean immigrant populations. It is a
é
4-year collaborative project between CIBERDEM and other European institutions. á
It is subsidized by the European Commission under its FP7-Health-2011-two-stage é

framework programme with project number 279171 and coordinated by Dr. Florin é

Grigorescu of the Universit Montpellier I, France.

Partners in the international consortium:

• University Montpellier 1 (UM1), UMR-204 NUTRIPASS Prévention des malnu-
tritions et des pathologies associes. Montpellier, France.

• Universite Lyon 1 Claude Bernard, Fdration d’Endocrinologie, HOPITAL NEU-

RO-CARDIO. Lyon-Bron, France.
ñ
13
• Centro de Investigacin Biomdica en Red de Diabetes y Enfermedades Meta- 20
blicas (CIBERDEM), Laboratorio de Diabetes y Obesidad (IDIBAPS). Barcelo- T
OR
na, Espaa.
P
RE
• Instituto Cataln de Arqueologa Clsica. Tarragona, Espaa. L
• University Of Medicine And Pharmacy Carol Davila, National Institute of Endo-
A
NU
crinology, Neuroendocrinology Laboratory. Bucharest, Romania.
N
A
• Alma Mater Studiorum-Universita Di Bologna, Division of Endocrinology, De- M /
partment of Internal Medicine. Bologna, Italy.
E
D
• Magna Graecia University Of Catanzaro, Laboratory of Internal Medicine, De- ER
B
partment of Experimental and Clinical Medicine. Catanzaro, Italy.
CI

• Scientific Institute Casa Sollievo Della Sofferenza, Department of Clinical 33
Science. Rome, Italy.